Tag:

vaccines

Latest Headlines

Latest Headlines

New study clears Merck's blockbuster Gardasil of MS risk

Good news for Merck: According to a new study, its cash cow vaccine, HPV-blocker Gardasil, isn't linked to an increased risk of multiple sclerosis--or any other similar CNS diseases, for that matter.

With Swiss pickup, Pfizer adds CMV candidate to growing vaccines unit

After 2014's growth spurt, Pfizer's vaccines unit is not done expanding. The pharma giant has grabbed privately held Swiss company Redvax for an undisclosed sum, adding a preclinical human cytomegalovirus (CMV) vaccine candidate and a tech platform and IP related to a second, undisclosed vaccine program.

UPDATED: Novartis flu vaccine under the lens as Italy probes 13 deaths

Italy's drug regulator has a growing investigation on its hands, and Novartis is in the middle of it. The number of people who have died in the country after receiving one of the Swiss pharma giant's flu vaccines has risen by 10 just days after Italy issued a partial ban on the product.

Merck in talks with NewLink to scale up Ebola vaccine production: Bloomberg

Merck may soon be the next Big Pharma to step into the Ebola vaccine arena.

Why the Bexsero delay? Novartis holding government to 'ransom,' U.K. says

The U.K. and Novartis have been negotiating for months now on a fair price for the Swiss pharma's meningitis B shot, Bexsero, which the country plans to add to its childhood vaccination schedule. So what's the holdup?

Novartis unloads last piece of vaccines puzzle to CSL for $275M

After a lengthy strategic review and a handful of divestments, Novartis' slim-down effort is finally coming to a close. The company has sold off its flu vaccines business--the only piece of the vaccines unit it hung onto after a multibillion-dollar April transaction with GlaxoSmithKline--to Australia's CSL.

EU official: Boar hunting should stop until African swine fever vax is developed

Hunting of infected boars is being blamed for the spread of African swine fever in Poland, Estonia, Latvia and Lithuania, according to a top European Commission animal health official, who also rebuffed claims the agency isn't doing enough to fight the virus.

Pan Genome Systems searching for money to fund new Johne's disease vaccine

Wisconsin-based Pan Genome Systems is looking for up to $2 million in funding to conduct trials for its live attenuated vaccine to combat Johne's disease.

Three European companies will team to develop VLP vaccines for vet use

Artes Biotechnology, InstrAction and Q-Biologicals have teamed to develop a virus-like particle vaccine platform for use in veterinary applications.

Glaxo Ebola vax shows no adverse effects so far in first human trial

With the Ebola death toll mounting in West Africa, a Phase I trial of GlaxoSmithKline's experimental vaccine for the disease is underway at the U.S. National Institutes of Health.